CI logo

The Cigna Group (CI) EBITDA

annual EBITDA:

$8.04B-$504.00M(-5.90%)
December 31, 2024

Summary

  • As of today (August 21, 2025), CI annual EBITDA is $8.04 billion, with the most recent change of -$504.00 million (-5.90%) on December 31, 2024.
  • During the last 3 years, CI annual EBITDA has fallen by -$1.66 billion (-17.11%).
  • CI annual EBITDA is now -41.16% below its all-time high of $13.67 billion, reached on December 31, 2020.

Performance

1-year change

-5.9%

3-year change

-17.11%

5-year change

-21.3%

15-year change

+92.81%

CI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.44%
CI annual EBITDA is higher than 98.44% of companies in Healthcare sector

Range

All-time high

$13.67B
CI annual EBITDA is currently -41.16% below its historical high of $13.67 billion

3-year low

$8.04B
CI annual EBITDA is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
CI previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
CI next annual earnings announcement has not yet been scheduled

OtherCIincome statement metrics

Annual revenue

$244.38B
CI annual revenue is $244.38 billion

annual net income

$3.78B
CI annual net profit is $3.78 billion

annual EBIT

$5.27B
CI annual earnings before interest & taxes is $5.27 billion

Annual EPS

$12.12
CI annual earnings per share is $12.12

quarterly EBITDA:

$2.70B+$381.00M(+16.41%)
June 30, 2025

Summary

  • As of today (August 21, 2025), CI quarterly EBITDA is $2.70 billion, with the most recent change of +$381.00 million (+16.41%) on June 30, 2025.
  • Over the past year, CI quarterly EBITDA has dropped by -$24.00 million (-0.88%).
  • CI quarterly EBITDA is now -55.62% below its all-time high of $6.09 billion, reached on December 31, 2020.

Performance

3-month change

+16.41%

1-year change

-0.88%

3-year change

-1.35%

5-year change

-9.39%

CI quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.61%
CI quarterly EBITDA is higher than 98.61% of companies in Healthcare sector

Range

All-time high

$6.09B
CI quarterly EBITDA is currently -55.62% below its historical high of $6.09 billion

3-year low

$820.00M
CI quarterly EBITDA is currently +229.63% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
CI previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
CI next earnings announcement is scheduled for Oct 30, 2025

OtherCIincome statement metrics

Quarterly revenue

$67.23B
CI quarterly revenue is $67.23 billion

quarterly net income

$1.63B
CI quarterly net profit is $1.63 billion

quarterly EBIT

$2.02B
CI quarterly earnings before interest & taxes is $2.02 billion

Quarterly EPS

$5.71
CI quarterly earnings per share is $5.71

TTM EBITDA:

$9.52B-$24.00M(-0.25%)
June 30, 2025

Summary

  • As of today (August 21, 2025), CI TTM EBITDA is $9.52 billion, with the most recent change of -$24.00 million (-0.25%) on June 30, 2025.
  • Over the past year, CI TTM EBITDA has increased by +$2.42 billion (+34.00%).
  • CI TTM EBITDA is now -31.04% below its all-time high of $13.81 billion, reached on March 31, 2021.

Performance

3-month change

-0.25%

1-year change

+34%

3-year change

-3.55%

5-year change

-4.18%

CI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.43%
CI TTM EBITDA is higher than 98.43% of companies in Healthcare sector

Range

All-time high

$13.81B
CI TTM EBITDA is currently -31.04% below its historical high of $13.81 billion

3-year low

$6.34B
CI TTM EBITDA is currently +50.14% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
CI previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 30, 2025
CI next earnings announcement is scheduled for Oct 30, 2025

OtherCIincome statement metrics

TTM revenue

$261.22B
CI TTM revenue is $261.22 billion

TTM net income

$5.40B
CI TTM net profit is $5.40 billion

TTM EBIT

$6.87B
CI TTM earnings before interest & taxes is $6.87 billion

TTM EPS

$18.32
CI TTM earnings per share is $18.32

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

annual EBITDA

$8.04B
CI annual EBITDA is $8.04 billion

annual net income

$3.78B
CI annual net profit is $3.78 billion

annual interest expense

$0.00
CI annual interest expense is $0.00

annual income tax

$1.49B
CI annual income tax is $1.49 billion

annual D&A

$2.77B
CI annual depreciation & amortization is $2.77 billion

CI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.9%-0.9%+34.0%
3 y3 years-17.1%-1.4%-3.5%
5 y5 years-21.3%-9.4%-4.2%

CI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-29.0%at low-35.9%+229.6%-16.5%+50.1%
5 y5-year-41.2%at low-55.6%+229.6%-31.0%+50.1%
alltimeall time-41.2%>+9999.0%-55.6%+320.1%-31.0%+1313.0%

CI EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.70B(+16.4%)
$9.52B(-0.3%)
Mar 2025
-
$2.32B(-12.5%)
$9.55B(+18.7%)
Dec 2024
$8.04B(-5.9%)
$2.65B(+44.1%)
$8.04B(+26.8%)
Sep 2024
-
$1.84B(-32.5%)
$6.34B(-10.8%)
Jun 2024
-
$2.73B(+232.6%)
$7.11B(+1.3%)
Mar 2024
-
$820.00M(-14.0%)
$7.02B(-17.9%)
Dec 2023
$8.55B(-24.6%)
$953.00M(-63.4%)
$8.55B(-11.8%)
Sep 2023
-
$2.61B(-1.3%)
$9.69B(-14.3%)
Jun 2023
-
$2.64B(+12.3%)
$11.30B(-0.9%)
Mar 2023
-
$2.35B(+12.3%)
$11.40B(+0.6%)
Dec 2022
$11.33B(+16.8%)
$2.09B(-50.4%)
$11.33B(+0.3%)
Sep 2022
-
$4.22B(+53.9%)
$11.30B(+14.4%)
Jun 2022
-
$2.74B(+20.0%)
$9.87B(+1.1%)
Mar 2022
-
$2.28B(+11.1%)
$9.76B(+0.6%)
Dec 2021
$9.71B(-29.0%)
$2.06B(-26.4%)
$9.71B(-29.4%)
Sep 2021
-
$2.79B(+6.2%)
$13.74B(+2.1%)
Jun 2021
-
$2.63B(+18.0%)
$13.45B(-2.6%)
Mar 2021
-
$2.23B(-63.4%)
$13.81B(+1.0%)
Dec 2020
$13.67B(+33.7%)
$6.09B(+143.1%)
$13.67B(+40.0%)
Sep 2020
-
$2.51B(-16.0%)
$9.77B(-1.7%)
Jun 2020
-
$2.98B(+42.7%)
$9.94B(+3.2%)
Mar 2020
-
$2.09B(-4.5%)
$9.63B(-5.8%)
Dec 2019
$10.22B(+139.0%)
$2.19B(-18.2%)
$10.22B(+20.0%)
Sep 2019
-
$2.68B(+0.1%)
$8.52B(+21.0%)
Jun 2019
-
$2.67B(-0.5%)
$7.04B(+25.6%)
Mar 2019
-
$2.69B(+453.6%)
$5.60B(+31.0%)
Dec 2018
$4.28B(+2.5%)
$485.00M(-59.4%)
$4.28B(-8.8%)
Sep 2018
-
$1.20B(-3.5%)
$4.69B(+5.2%)
Jun 2018
-
$1.24B(-8.8%)
$4.46B(-0.8%)
Mar 2018
-
$1.36B(+51.1%)
$4.49B(+7.7%)
Dec 2017
$4.17B(+16.2%)
$899.00M(-6.6%)
$4.17B(+3.6%)
Sep 2017
-
$963.00M(-24.4%)
$4.03B(+1.8%)
Jun 2017
-
$1.27B(+23.0%)
$3.96B(+8.5%)
Mar 2017
-
$1.04B(+37.2%)
$3.65B(+1.6%)
Dec 2016
$3.59B(-8.3%)
$755.00M(-15.4%)
$3.59B(-1.0%)
Sep 2016
-
$892.00M(-7.6%)
$3.63B(-3.6%)
Jun 2016
-
$965.00M(-1.2%)
$3.76B(-3.1%)
Mar 2016
-
$977.00M(+23.2%)
$3.88B(-0.7%)
Dec 2015
$3.91B(+0.5%)
$793.00M(-22.8%)
$3.91B(-2.3%)
Sep 2015
-
$1.03B(-5.5%)
$4.00B(+1.6%)
Jun 2015
-
$1.09B(+8.2%)
$3.94B(+1.2%)
Mar 2015
-
$1.00B(+13.6%)
$3.89B(+0.1%)
Dec 2014
$3.89B(+40.4%)
$885.00M(-8.2%)
$3.89B(+5.3%)
Sep 2014
-
$964.00M(-7.3%)
$3.69B(+0.5%)
Jun 2014
-
$1.04B(+3.7%)
$3.68B(+3.5%)
Mar 2014
-
$1.00B(+45.8%)
$3.55B(+28.1%)
Dec 2013
$2.77B(-8.7%)
$688.00M(-27.2%)
$2.77B(-3.0%)
Sep 2013
-
$945.00M(+3.2%)
$2.86B(+3.3%)
Jun 2013
-
$916.00M(+308.9%)
$2.77B(+7.1%)
Mar 2013
-
$224.00M(-71.0%)
$2.58B(-14.9%)
Dec 2012
$3.04B(+36.7%)
$773.00M(-9.5%)
$3.04B(+8.9%)
Sep 2012
-
$854.00M(+16.7%)
$2.79B(+21.6%)
Jun 2012
-
$732.00M(+8.0%)
$2.29B(+2.5%)
Mar 2012
-
$678.00M(+29.1%)
$2.24B(+0.7%)
Dec 2011
$2.22B(+2.7%)
$525.00M(+46.2%)
$2.22B(-4.6%)
Sep 2011
-
$359.00M(-46.8%)
$2.33B(-7.2%)
Jun 2011
-
$675.00M(+2.0%)
$2.51B(+7.2%)
Mar 2011
-
$662.00M(+4.6%)
$2.34B(+8.3%)
Dec 2010
$2.16B
$633.00M(+17.2%)
$2.16B(+3.1%)
DateAnnualQuarterlyTTM
Sep 2010
-
$540.00M(+6.7%)
$2.10B(-0.4%)
Jun 2010
-
$506.00M(+4.8%)
$2.11B(-8.7%)
Mar 2010
-
$483.00M(-15.1%)
$2.31B(+6.5%)
Dec 2009
$2.17B(+248.2%)
$569.00M(+3.6%)
$2.17B(+64.1%)
Sep 2009
-
$549.00M(-22.2%)
$1.32B(+23.7%)
Jun 2009
-
$706.00M(+106.4%)
$1.07B(+27.3%)
Mar 2009
-
$342.00M(-223.5%)
$838.00M(+34.7%)
Dec 2008
$622.00M(-65.9%)
-$277.00M(-193.6%)
$622.00M(-53.4%)
Sep 2008
-
$296.00M(-37.9%)
$1.33B(-16.0%)
Jun 2008
-
$477.00M(+278.6%)
$1.59B(+7.1%)
Mar 2008
-
$126.00M(-71.0%)
$1.48B(-18.7%)
Dec 2007
$1.82B(-5.9%)
$435.00M(-21.1%)
$1.82B(+1.8%)
Sep 2007
-
$551.00M(+48.1%)
$1.79B(+3.3%)
Jun 2007
-
$372.00M(-20.3%)
$1.74B(-4.9%)
Mar 2007
-
$467.00M(+16.2%)
$1.82B(-5.9%)
Dec 2006
$1.94B(-3.7%)
$402.00M(-18.6%)
$1.94B(+2.3%)
Sep 2006
-
$494.00M(+7.2%)
$1.90B(+2.9%)
Jun 2006
-
$461.00M(-20.8%)
$1.84B(-1.4%)
Mar 2006
-
$582.00M(+62.1%)
$1.87B(-7.2%)
Dec 2005
$2.01B(-4838.8%)
$359.00M(-18.6%)
$2.01B(-18.4%)
Sep 2005
-
$441.00M(-9.4%)
$2.47B(-5.1%)
Jun 2005
-
$487.00M(-33.0%)
$2.60B(-11.0%)
Mar 2005
-
$727.00M(-10.7%)
$2.93B(+13.7%)
Dec 2004
-
$814.00M(+41.6%)
$2.57B(+15.1%)
Sep 2004
-
$575.00M(-29.0%)
$2.23B(+11.1%)
Jun 2004
-
$810.00M(+116.6%)
$2.01B(+70.7%)
Mar 2004
-
$374.00M(-21.4%)
$1.18B(+2.5%)
Dec 2003
-
$476.00M(+35.6%)
$1.15B(+44.7%)
Sep 2003
-
$351.00M(-1626.1%)
$794.00M(-201.1%)
Jun 2003
-
-$23.00M(-106.7%)
-$785.00M(+99.2%)
Mar 2003
-
$345.00M(+185.1%)
-$394.00M(+13.2%)
Dec 2002
-
$121.00M(-109.9%)
-$348.00M(+163.6%)
Sep 2002
-
-$1.23B(-433.7%)
-$132.00M(-108.4%)
Jun 2002
-
$368.00M(-5.9%)
$1.57B(-4.4%)
Mar 2002
-
$391.00M(+16.0%)
$1.64B(-5.1%)
Dec 2001
-
$337.00M(-29.1%)
$1.73B(-6.4%)
Sep 2001
-
$475.00M(+7.7%)
$1.85B(-0.3%)
Jun 2001
-
$441.00M(-7.9%)
$1.86B(+7.9%)
Mar 2001
-
$479.00M(+5.0%)
$1.72B(+0.2%)
Dec 2000
-
$456.00M(-5.2%)
$1.72B(-2.4%)
Sep 2000
-
$481.00M(+57.7%)
$1.76B(+36.4%)
Jun 2000
-
$305.00M(-35.9%)
$1.29B(-13.8%)
Mar 2000
-
$476.00M(-4.4%)
$1.50B(-0.6%)
Dec 1999
-
$498.00M(+4427.3%)
$1.51B(+5.2%)
Sep 1999
-
$11.00M(-97.9%)
$1.43B(-23.7%)
Jun 1999
-
$512.00M(+5.6%)
$1.88B(+0.6%)
Mar 1999
-
$485.00M(+14.4%)
$1.87B(-16.2%)
Dec 1998
-
$424.00M(-7.2%)
$2.23B(+12.4%)
Sep 1998
-
$457.00M(-8.8%)
$1.98B(+29.9%)
Jun 1998
-
$501.00M(-40.8%)
$1.53B(+57.2%)
Mar 1998
-
$846.00M(+372.6%)
$971.00M(+442.5%)
Dec 1997
-
$179.00M(-431.5%)
$179.00M(>+9900.0%)
Jun 1997
-
-$54.00M(-200.0%)
$0.00(-100.0%)
Mar 1997
-
$54.00M
$54.00M
Dec 1984
-$42.50M(-117.4%)
-
-
Dec 1983
$244.50M(-49.2%)
-
-
Dec 1982
$481.50M(+20.6%)
-
-
Dec 1981
$399.29M(+6.5%)
-
-
Dec 1980
$374.85M
-
-

FAQ

  • What is The Cigna Group annual EBITDA?
  • What is the all time high annual EBITDA for The Cigna Group?
  • What is The Cigna Group annual EBITDA year-on-year change?
  • What is The Cigna Group quarterly EBITDA?
  • What is the all time high quarterly EBITDA for The Cigna Group?
  • What is The Cigna Group quarterly EBITDA year-on-year change?
  • What is The Cigna Group TTM EBITDA?
  • What is the all time high TTM EBITDA for The Cigna Group?
  • What is The Cigna Group TTM EBITDA year-on-year change?

What is The Cigna Group annual EBITDA?

The current annual EBITDA of CI is $8.04B

What is the all time high annual EBITDA for The Cigna Group?

The Cigna Group all-time high annual EBITDA is $13.67B

What is The Cigna Group annual EBITDA year-on-year change?

Over the past year, CI annual EBITDA has changed by -$504.00M (-5.90%)

What is The Cigna Group quarterly EBITDA?

The current quarterly EBITDA of CI is $2.70B

What is the all time high quarterly EBITDA for The Cigna Group?

The Cigna Group all-time high quarterly EBITDA is $6.09B

What is The Cigna Group quarterly EBITDA year-on-year change?

Over the past year, CI quarterly EBITDA has changed by -$24.00M (-0.88%)

What is The Cigna Group TTM EBITDA?

The current TTM EBITDA of CI is $9.52B

What is the all time high TTM EBITDA for The Cigna Group?

The Cigna Group all-time high TTM EBITDA is $13.81B

What is The Cigna Group TTM EBITDA year-on-year change?

Over the past year, CI TTM EBITDA has changed by +$2.42B (+34.00%)
On this page